Neuroendocrine Tumor Clinical Trials

Find Neuroendocrine Tumor Clinical Trials Near You

Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America

Status: Recruiting
Location: See all (19) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

This observational, retrospective study aims to understand the treatment patterns and outcomes of patients with pulmonary and extra-pulmonary neuroendocrine carcinomas (NEC) in Latin America (Brazil, Mexico, Argentina, and Peru). The research will collect data from medical records to analyze factors like patient demographics, diagnosis methods, tumor characteristics, treatment approaches, and disease progression. The study is non-interventional, meaning patient care will follow standard clinical practice, with data gathered via an electronic system.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• ≥18 years old

• Diagnosed between August 2014 and August 2024 with one of the following:

• Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)

• Large-cell neuroendocrine carcinoma (LCNEC) or mixed

• Small Cell Lung Cancer (SCLC) or mixed

• Adequate and accessible medical records for data collection

• Tumor block collected from 2014 onwards

Locations
Other Locations
Argentina
Hospital Británico de Buenos Aires
RECRUITING
Buenos Aires
Hospital de Gastroenterología Carlos Bonorino Udaondo
RECRUITING
Buenos Aires
Instituto Alexander Fleming
RECRUITING
Buenos Aires
Brazil
Oncocentro de Minas Gerais (Oncoclínicas)
ACTIVE_NOT_RECRUITING
Belo Horizonte
Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO)
ACTIVE_NOT_RECRUITING
Cachoeiro De Itapemirim
Clínica Prognóstica - Centro de Pesquisa Clínica Onconeo
ACTIVE_NOT_RECRUITING
Campo Grande
IOP Pesquisa - Instituto de Oncologia do Paraná
ACTIVE_NOT_RECRUITING
Curitiba
ANIMI - Unidade de Tratamento Oncológico
ACTIVE_NOT_RECRUITING
Lages
HCL - Hospital do Câncer de Londrina
ACTIVE_NOT_RECRUITING
Londrina
HUOL - Hospital Universitário Onofre Lopes da UFRN
ACTIVE_NOT_RECRUITING
Natal
Liga Norte Riograndense Contra o Câncer
ACTIVE_NOT_RECRUITING
Natal
Futtura Oncologia - Hub de Pesquisa Clínica
ACTIVE_NOT_RECRUITING
Porto Alegre
HMV - Hospital Moinhos de Vento
ACTIVE_NOT_RECRUITING
Porto Alegre
INCA - Instituto Nacional de Câncer
ACTIVE_NOT_RECRUITING
Rio De Janeiro
A.C. Camargo Cancer Center
ACTIVE_NOT_RECRUITING
São Paulo
HIAE - Hospital Israelita Albert Einstein
ACTIVE_NOT_RECRUITING
São Paulo
Mexico
Centro Oncológico Internacional (COI)
ACTIVE_NOT_RECRUITING
Mexico City
INCan - Instituto Nacional de Cancerología
ACTIVE_NOT_RECRUITING
Mexico City
Peru
Oncosalud AUNA
RECRUITING
Lima
Contact Information
Primary
Project Manager
lacog1324@lacog.group
+55 51 3384 5334
Backup
Laura Voelcker
laura.voelcker@lacog.group
+55 51 3384 5334
Time Frame
Start Date: 2025-12-16
Estimated Completion Date: 2026-09
Participants
Target number of participants: 200
Treatments
Patients with extra-pulmonary neuroendocrine carcinoma
Patients with Extrapulmonary Neuroendocrine Carcinoma (EP-NEC), diagnosed between August 2014 and August 2024.
Patients with pulmonary neuroendocrine carcinoma
Patients with Large-cell neuroendocrine carcinoma (LCNEC) or mixed and patients with Small Cell Lung Cancer (SCLC) or mixed, diagnosed between August 2014 and August 2024.
Related Therapeutic Areas
Sponsors
Collaborators: Boehringer Ingelheim, Grupo Argentino de Investigación Clínica en Oncología, Grupo de Estudios Clínicos Oncológicos Peruano
Leads: Latin American Cooperative Oncology Group

This content was sourced from clinicaltrials.gov